Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Octapharma: Clinical Trials & FDA Approval Profile

Octapharma (Global / Institutional) sponsors 17 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 6 active protocols (5 recruiting now), 7 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)23.5%
Median Closed Enrollment vs National (145 pts)64 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Octapharma
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)17
Active Pipeline (Recruiting Now)6 (5)
Completed vs Stopped Early7 / 4 (23.5%)
Median Closed Actual Enrollment64 participants
Physical Hospital Site Disclosure99.7% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Octapharma
Hospital Research SiteLocationShared Protocols
Duke University Medical CenterDurham, NC3
Toronto General HospitalToronto, Ontario2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Octapharma
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07220915Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent InfectionsPhase IIIRECRUITING
NCT04918173Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or DeliveryPhase IIIRECRUITING
NCT06096116Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to UndergoPhase IIIRECRUITING
NCT04867837Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa InhibitorPhase IIITERMINATED

Explore interactive annual charts and M&A subsidiary rollups in the Octapharma Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI